Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from LLY

Funds Load Up On Costco, Eli Lilly, These Other Stocks

Fund managers have been busy buying amid the ongoing market weakness. Four stocks are near buy points or are building bases.

Investors Business Daily

Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review

Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review

Monday's global sell-off turned into a stock market rally attempt. Palantir, Eli Lilly and Fortinet were among the earnings winners.

Investors Business Daily

Eli Lilly Stock: Analyst Estimates & Ratings

Eli Lilly Stock: Analyst Estimates & Ratings

Eli Lilly has significantly outperformed the broader market over the past year, and Wall Street analysts are bullish about the stock’s prospects.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Stock Market Today: Stocks Rally as Recession Fears Ease

Initial jobless claims fell more than expected last week, which helped calm fears of a slowing labor market.

Eli Lilly's Weight-Loss Drugs Fuel Beat-And-Raise Quarter

Eli Lilly stock is surging after the pharma giant beat Q2 estimates and lifted its full-year outlook. Here's what you need to know.

3 Healthcare Innovators With Game-Changing Treatments

The pharmaceutical industry’s long-term growth is fueled by a surge in demand for personalized medicine, rising R&D initiatives, and the adoption of cutting-edge technologies. Hence, it could be ideal to buy fundamentally solid pharma stocks, Eli Lilly (LLY), Bristol-Myers (BMY), and Merck & Co. (MRK), which look poised for blockbuster…

3 Leading S&P 500 Stocks Set to Climb Even Higher

As the stock market evolves, leading S&P 500 stocks like Eli Lilly and Company (LLY), Howmet Aerospace (HWM), and NetApp (NTAP) are well-positioned to capitalize on current market conditions and climb higher. Read on….

inkl

Read news from The Economist, FT, and more,
with one subscription

What You Need to Know Ahead of Eli Lilly's Earnings Release

What You Need to Know Ahead of Eli Lilly's Earnings Release

As Eli Lilly gears up to release its second-quarter earnings next month, analysts project a double-digit bottom-line growth.

Dow Jones Futures: Netflix Subscribers Jump As Tesla, Nvidia Resilient; President Biden Buzz Heats Up

Dow Jones Futures: Netflix Subscribers Jump As Tesla, Nvidia Resilient; President Biden Buzz Heats Up

Stocks retreated Thursday, but Tesla and Nvidia were resilient. Netflix subscribers jumped. President Biden may be close to dropping out, but reports differ.

Investors Business Daily

3 Pharmaceutical Stocks With Strong Pipelines

3 Pharmaceutical Stocks With Strong Pipelines

The pharmaceutical industry is flourishing due to increasing medical demands and rising healthcare spending worldwide. Hence, pharma stocks Eli Lilly (LLY), Johnson & Johnson (JNJ), and Merck & Co. (MRK), with strong pipelines, might be worth buying. Read more….

The Next $1 Trillion Stock? AI Play Briefly Joins Club; Tesla, Warren Buffett's Berkshire Hathaway Close

The Next $1 Trillion Stock? AI Play Briefly Joins Club; Tesla, Warren Buffett's Berkshire Hathaway Close

Which will be the next $1 trillion stock? Taiwan Semiconductor briefly joined the club Monday. Tesla and Warren Buffett's Berkshire are getting closer.

Investors Business Daily

Novo, Lilly Fall After Biden Slams Duo For 'Unconscionably High' Drug Prices

Novo, Lilly Fall After Biden Slams Duo For 'Unconscionably High' Drug Prices

Novo Nordisk stock fell Tuesday after Joe Biden and Bernie Sanders slammed the drugmaker and Eli Lilly for high prices of weight-loss drugs.

Investors Business Daily

3 Mega-Cap Stocks to Consider Before They're Worth $1 Trillion

3 Mega-Cap Stocks to Consider Before They're Worth $1 Trillion

Mega-cap stocks are the flavor of the season, and these three big names are the next set of contenders racing towards the $1 trillion market cap club.

Eli Lilly Stock: Is LLY Outperforming the Healthcare Sector?

Eli Lilly Stock: Is LLY Outperforming the Healthcare Sector?

Eli Lilly has outperformed the healthcare sector over the past three months, but analysts remain cautiously optimistic about the stock’s prospects.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

LLY Stock Today: How To Trade An Unbalanced Iron Condor That May Put $285 In Your Pocket

The profit zone ranges between 757.15 and 912.85.

3 Pharma Stocks Poised for Big Returns This Summer

The pharmaceutical industry is expected to grow rapidly due to the ever-rising healthcare needs and the incorporation of cutting-edge technologies into drug manufacturing. Hence, pharma stocks Eli Lilly (LLY), Green Thumb Industries (GTBIF), and Supernus Pharmaceuticals (SUPN) might be worth buying for returns this summer. Read more….

Investors Business Daily

S&P 500 Giants Lead Five Healthy Stocks Near Buy Points

Eli Lilly is in a buy zone, while weight-loss drug rival Novo Nordisk just forged a lower entry.

Do Wall Street Analysts Like Eli Lilly Stock?

Eli Lilly stock has outperformed the broader market over the past year, and Wall Street analysts remain optimistic about the stock’s prospect.

Get all your
news in one place.

100’s of premium titles.
One news app.

Eli Lilly (LLY) vs. Novo Nordisk (NVO): Which Pharma Stock Is Driving Long-Term 2024 Profits?

The pharmaceutical market is poised for rapid expansion due to rising global medical needs and increasing integration of technologies in drug discovery and development. Amid this, let’s analyze Eli Lilly (LLY) and Novo Nordisk (NVO) to determine which pharma stock will drive long-term profits in 2024. Read more to find…

Investors Business Daily

Dow Jones Futures Fall As Target Tumbles; Nvidia Looms Over Stock Market

The Nasdaq hit a new high Tuesday but Target tumbled early Wednesday. Will Nvidia earnings tonight meet lofty hopes?

1 'Strong Buy' Dividend Stock to Buy and Hold

Discover why Eli Lilly is considered a 'strong buy' as it capitalizes on the growing demand for diabetes and obesity treatments, backed by its robust financial performance and promising future prospects.

Eli Lilly (LLY) or Pfizer (PFE): Which Stock Can Surge From Earnings?

Amid increasing healthcare spending, breakthroughs in genomics and personalized medicine, and the adoption of new technologies, the pharma industry is booming. So, let’s analyze Eli Lilly (LLY) and Pfizer (PFE) to determine which pharma stock will surge from their first-quarter earnings. Read on to find out.

Investors Business Daily

Dow Jones Futures Fall As Fed Looms; Amazon Rises As AMD, Super Micro Plunge

The market rally stumbled ahead of the Fed meeting. Amazon rose on earnings while AI plays Super Micro and AMD plunged.

Investors Business Daily

Dow Jones Futures: Market Rally Holds Support, Meta Near Buy Point; Tesla Skid Continues

Stocks retreated Tuesday as Treasury yields hit 2024 highs. Tesla tumbled, but Meta and Eli Lilly are hanging tough.

Investors Business Daily

Dow Jones Futures: Small Caps Jump As Nvidia, Growth Leaders Skid

Small caps lead the stock market's broad advance Wednesday, but Nvidia and other growth leaders retreated.

People

Mangeet Kaur BounsMangeet

Christopher Waller

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

260,088 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play